Overall survival after DCD transplantation was significantly impaired only in certain cohorts such as those with AFP > 100 ng/mL, Risk Estimation of Tumor Recurrence after Transplant (RETREAT) score ≥ 4, and in recipients with contrast-enhanced multiple liver lesions found in radiological studies directly before surgery [39]. This evidence concerns the gene AFP and neoplasm.